Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-02-03

FDA Approved: PREPIDIL — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

FDA approved a supplemental application for PREPIDIL (dinoprostone) filed by Pharmacia & Upjohn Company LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREPIDIL (dinoprostone)

Snippet

SUPPL AP for PREPIDIL (DINOPROSTONE)